phosphorus has been researched along with Bone Loss, Perimenopausal in 104 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (1.92) | 18.7374 |
1990's | 39 (37.50) | 18.2507 |
2000's | 34 (32.69) | 29.6817 |
2010's | 26 (25.00) | 24.3611 |
2020's | 3 (2.88) | 2.80 |
Authors | Studies |
---|---|
Chen, T; Li, G; Xu, Y | 1 |
Iba, K; Sonoda, T; Takada, J; Yamashita, T | 1 |
Di Bonito, M; Ferretti, V; Giampà, E; Nuvoli, G; Paoletti, F; Piazzini, M; Ranieri, M; Tuveri, MA; Vinicola, V | 1 |
Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
Chen, YJ; Du, YN; Jin, XJ; Wang, X; Zhang, HY; Zhang, ZF | 1 |
Hoffmann, DB; Komrakova, M; Lehmann, W; Pflug, S; Saul, D; Schilling, AF; Sehmisch, S; von Oertzen, M; Walde, TA; Wassmann, M; Weiser, L | 1 |
Alahmari, AD; Ayed, MS; Diab, HM; Divakar, DD; Shafiq, SS | 1 |
Deng, Y; Ma, X; Sun, A; Wang, YF; Xue, W; Zhu, SY | 1 |
Deng, J; Feng, Z; Li, Q; Li, Y; Pan, T; Zhao, C | 1 |
Huang, W; Liu, H; Tao, XZ; Tian, N; Wang, MX; Yang, K | 1 |
Cao, SS; Denney, L; Dong, XL; Feng, HT; Gao, QG; Wong, MS | 1 |
El Khassawna, T; Govindarajan, P; Heiss, C; Henss, A; Janek, J; Rohnke, M; Schlewitz, G | 1 |
Bansal, N; Budoff, MJ; Criqui, MH; de Boer, IH; Hoofnagle, AN; Ix, JH; Katz, R; Kestenbaum, B; Laughlin, GA; Li, D; Siscovick, DS; Tracy, R | 1 |
Abali, R; Celik Guzel, E; Celik, E; Guzel, S; Guzelant, AY; Kuçukyalcin, V | 1 |
Cheng, Q; Jiang, Y; Liu, JL; Meng, XW; Wu, FL; Wu, YY; Xing, XP; Yu, W; Zhang, ZL; Zhu, HM | 1 |
Bouhsain, S; Chabraoui, L; Dami, A; Elmaataoui, A; Elmachtani Idrissi, S; Ouzzif, Z | 1 |
Farbodara, T; Haghverdi, F; Mortaji, S; Saidi, N; Soltani, P | 1 |
Fu, Q; Ren, Z; Shen, T; Wang, C; Wang, G; Wang, Y; Wu, L; Zhang, J | 1 |
Chen, Q; Fan, X; Huang, H; Li, B; Liu, H; Wang, F; Wu, B; Wu, D; Zheng, Xh | 1 |
Denisova, SN; Kondrashov, AA; Muradiants, AA; Shostak, NA | 1 |
Chen, B; Chen, J; Huang, H; Li, H; Pang, G; Xie, J | 1 |
Chiu, HF; Law, YY; Lee, HH; Shen, YC; Venkatakrishnan, K; Wang, CK | 1 |
Larin, OS; Ziablitsev, DS | 1 |
Anastasilakis, AD; Avramidis, A; Efstathiadou, Z; Goulis, DG; Kita, M; Koukoulis, G; Polyzos, SA; Slavakis, A | 1 |
Li, H; Wang, SX | 1 |
Fantasia, JE | 1 |
Dong, CL; Du, J; Li, SW; Wu, JF; Zhang, X; Zhang, YP; Zheng, CX | 1 |
Kuroda, T; Nakamura, T; Narusawa, K; Shiraki, M; Shiraki, Y; Tanaka, S | 1 |
Grases, F; López-González, ÁA; Perelló, J; Prieto, RM; Sanchis, P | 1 |
Fukagawa, M; Itoh, K; Kawanishi, H; Matsushita, K; Moriishi, M; Tanaka, M | 1 |
Arabi, A; Baddoura, R; El-Hajj Fuleihan, G; El-Rassi, R | 1 |
Arévalo González, E; Hernández, G; José Ramón, V; Josefina Linares, L; Marino Alarcón, O; Mora Mora, M; Urdaneta Romero, H | 1 |
Atkinson, EJ; Gössl, M; Kane, TL; Khosla, S; Lerman, A; McCready, LK; McGregor, UI; Peris, P | 1 |
Cincotta, M; Crisafulli, G; Frisina, N; Gaudio, A; Lasco, A; Morabito, N; Pizzoleo, MA; Tallarida, F; Trifiletti, A; Vergara, C | 1 |
Ichimura, S; Iwamoto, J; Takeda, T; Uzawa, M | 1 |
Chylova, K; Dzurik, R; Krivosikova, Z; Spustova, V; Stefikova, K | 1 |
Griffith, CS; Pak, CY; Poindexter, JR; Sakhaee, K | 1 |
Fukunaga, M; Inoue, T; Kaneda, K; Kishimoto, H; Kushida, K; Morii, H; Nakamura, T; Nakashima, M; Orimo, H; Shiraki, M; Yamamoto, K | 1 |
Iwamoto, J; Sato, Y; Takeda, T; Uzawa, M | 3 |
Kopaliani, M | 2 |
Frigato, M; Gnudi, S; Malavolta, N; Mascia, ML; Mulè, R; Pratelli, L | 1 |
Cimrin, D; Gol, M; Irmak, E; Uretmen, S | 1 |
Capar, M; Köşüş, A; Köşüş, N | 1 |
Cantor, P; Deal, C; Eriksen, EF; Glass, EV; Krege, JH; Myers, SL; Omizo, M; Schwartz, EN; Wang, J | 1 |
Barton, IP; Boonen, S; Burgio, DE; Dunlap, LE; Miller, PD; Roux, C | 1 |
Kim, MS; Lee, YS | 1 |
Booth, SL; do Rosário Dias de Oliveira Latorre, M; Martini, LA; Saltzman, E; Wood, RJ | 1 |
Cortet, B | 1 |
Akçay, A; Bavbek, N; Inegöl, I; Kanbay, M; Turgut, FH; Uz, E; Yanik, B; Yanik, T | 1 |
Aydin, K; Guclu, F; Hekimsoy, Z; Kafesciler, SO; Kirmaz, C; Ozmen, B | 1 |
Anastasilakis, AD; Avramidis, A; Gerou, S; Goulis, DG; Koukoulis, G; Pavlidou, V; Polyzos, SA | 1 |
Binnur Erbagci, A; Celik, A; Namiduru, ES; Tarakçioglu, M; Yilmaz, M | 1 |
Brown, IN; Cohen, A; Fleischer, JB; Hershman, DL; Joe, AK; Johnson, MK; McMahon, DJ; Silverberg, SJ | 1 |
Arisawa, K; Hiyoshi, M; Irahara, M; Miyatani, Y; Uemura, H; Yamada, M; Yasui, T | 1 |
Cao, DP; Han, T; Qin, LP; Rahman, K; Zhang, H; Zhang, QY; Zheng, YN | 1 |
Criddle, A; Devine, A; Dick, I; Garcia-Webb, P; Gutteridge, DH; Kerr, D; Price, RI; Prince, RL; St John, A | 1 |
Cosman, F; Lindsay, R; Nieves, J; Shen, V | 1 |
Champney, TH; Kubena, KS; Sampson, HW; Walker, M; Yee, CD | 1 |
Li, H; Liu, S; Tan, J; Zheng, Z | 1 |
Bonjour, JP; Rizzoli, R | 1 |
Heaney, RP; Recker, RR | 1 |
Li, H; Liu, S; Yang, C; Zhang, M; Zhang, Y | 1 |
Hanhijärvi, H; Hyvönen, PM; Karhi, T; Kosma, VM; Liimola-Luoma, L | 1 |
Ezawa, I; Jiu, LJ; Morikawa, N; Omi, N | 1 |
Garzetti, GG; Lucino, E; Romanini, C; Tranquilli, AL | 1 |
Avella, M; Bertocchi, G; Gandolfi, MG; Giardino, R; Giavaresi, GL; Gnudi, S; Mongiorgi, R; Zati, A | 1 |
Figus, E; Fini, M; Giardino, R; Gnudi, S; Orlandi, M; Pratelli, L; Zati, A | 1 |
Harris, ST; Morris, RC; Ottaway, JH; Sebastian, A; Todd, KM | 1 |
Biberoğlu, K; Kandemir, O; Yildiz, A | 1 |
Ferrante, B; Isa, L; Uderzo, A | 1 |
Hietala, EL | 1 |
Alekel, L; Amin, D; Arjmandi, BH; Guo, P; Hollis, BW; Kukreja, SC; Stacewicz-Sapuntzakis, M | 1 |
Goto, T; Kuwata, T; Shimizu, T; Tsuchita, H; Yonehara, Y | 1 |
Casao, E; Cervera, P; Elósegui, LM; Escanero, JF; Ibáñez, MA; Vidal, MD | 1 |
Butterfield, GE; Ghiron, LJ; Hintz, RL; Hoffman, AR; Holloway, L; Marcus, R; Thompson, JL | 1 |
Blonder, J; Frenkel, Y; Herzberg, M; Lusky, A | 1 |
Dick, IM; Heal, S; Prince, RL; St John, A | 1 |
Horiguchi, F; Komukai, S; Makita, K; Masuda, A; Nozawa, S; Ohta, H; Suda, Y; Sugimoto, I; Takamatsu, K | 1 |
Barth, CA; Delling, G; Jungblut, PW; Kallweit, E; Scholz-Ahrens, KE | 1 |
Hackeng, WH; Koster, JC; Mulder, H | 1 |
Aguado, F; Fraile, E; Hermandez, ER; Revilla, M; Rico, H; Villa, LF | 1 |
Fukunaga, M; Inoue, T; Kaneda, K; Kishimoto, H; Kushida, K; Minaguchi, H; Nagata, Y; Nakashima, M; Orimo, H; Shiraki, M; Tomita, A | 1 |
Miura, T; Nakano, M | 1 |
Baumgartner, RN; Bou-Serhal, CE; Clemens, JD; Garry, PJ; Glew, RH; Scariano, JK | 1 |
Barnhill, SD; Beer, R; Madyastha, KR | 1 |
Chaki, O; Gorai, I; Katagiri, N; Minaguchi, H; Misu, Y; Nakayama, M; Osada, H; Suzuki, N; Taguchi, Y | 1 |
Gnudi, S; Malavolta, N; Ripamonti, C; Veronesi, M; Zanardi, M | 1 |
Debari, K; Furuya, R; Kawawa, T; Sasaki, T; Shimizu, M; Tanaka, S | 1 |
Faĭvishevskiĭ, ML; Furtseva, LN; Rodionova, SS | 1 |
Ichimura, S; Iwamoto, J; Takeda, T | 1 |
Biberoğlu, K; Noyan, V; Tiraş, MB; Yildiz, A | 1 |
Esedova, AE; Ferzilaeva, RA; Gadzhieva, MM | 1 |
Higgins, J; Lukert, B; Stoskopf, M | 1 |
Audran, M; Gillabert, P; Girardeau, C; Giraud, P; Jallet, P; Renier, JC | 1 |
Anger, MS; Kowalski, L; McIntyre, DO; Miller, PD; Neal, BJ; Yanover, MJ | 1 |
Kohara, N | 1 |
Cabranes, JA; Escudero, G; Hernandez, ER; Pérez del Molino, J; Rico, H | 1 |
Frenchek, B; Speroff, L; Speroff, T; Williams, SR | 1 |
Drezner, MK; Nesbitt, T | 1 |
Pietschmann, P; Resch, H; Willvonseder, R | 1 |
Honjo, S; Igarashi, M; Mizunuma, H; Soda, M | 1 |
4 review(s) available for phosphorus and Bone Loss, Perimenopausal
Article | Year |
---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials.
Topics: Age Factors; Aged; Aged, 80 and over; Algorithms; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Calcium; Clinical Trials, Phase III as Topic; Creatine; Double-Blind Method; Etidronic Acid; Female; Humans; Kidney Function Tests; Osteoporosis, Postmenopausal; Phosphorus; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Retrospective Studies; Risedronic Acid; Treatment Outcome; Urinary Tract Infections | 2005 |
[Diagnosing osteoporosis: Laboratory tests].
Topics: Adult; Biomarkers; Bone Density; Bone Remodeling; Calcium; Diagnosis, Differential; Female; Humans; Hydrocortisone; Hyperparathyroidism, Primary; Middle Aged; Osteomalacia; Osteoporosis; Osteoporosis, Postmenopausal; Phosphorus; Risk Factors; Vitamin D Deficiency | 2006 |
[Investigation of phosphorus calcium metabolism after oral phosphorus supplementation].
Topics: Administration, Oral; Adult; Age Factors; Calcium; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus | 1992 |
35 trial(s) available for phosphorus and Bone Loss, Perimenopausal
Article | Year |
---|---|
Study on the Effect of Bushen Zhuanggu Tablet Combined with Conventional Regimen on Bone Mineral Density Improvement, Functional Recovery and Fracture Risk Prevention in Patients with Postmenopausal Osteoporosis.
Topics: Bone Density; Calcium; Case-Control Studies; Female; Fractures, Bone; Humans; Osteoporosis, Postmenopausal; Phosphorus; Quality of Life; Vitamin D | 2023 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Bone protection for early menopausal women in China: standard or half-dose estrogen with progestin? A one-year prospective randomized trail.
Topics: Alanine Transaminase; Alkaline Phosphatase; Bone Density; Calcium; Drug Therapy, Combination; Dydrogesterone; Endometrium; Estrogens; Estrogens, Conjugated (USP); Female; Femur Neck; Fractures, Bone; Humans; Lumbar Vertebrae; Middle Aged; Organ Size; Osteoporosis, Postmenopausal; Phosphorus; Progestins | 2019 |
Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial.
Topics: Aged; Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Calcium; Double-Blind Method; Female; Fractures, Bone; Humans; Hydroxycholecalciferols; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Phosphorus; Treatment Outcome; Vitamin K 2 | 2014 |
Effect of raloxifene on parathyroid hormone in osteopenic and osteoporotic postmenopausal women with chronic kidney disease stage 5.
Topics: Administration, Oral; Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Raloxifene Hydrochloride; Renal Dialysis; Renal Insufficiency, Chronic | 2014 |
Consumption of onion juice modulates oxidative stress and attenuates the risk of bone disorders in middle-aged and post-menopausal healthy subjects.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antioxidants; Bone Density; Calcium; Cell Differentiation; Cell Survival; Double-Blind Method; Female; Flavonoids; Fruit and Vegetable Juices; Humans; Hydrogen Peroxide; Male; Mice; Middle Aged; Onions; Osteogenesis; Osteoporosis, Postmenopausal; Oxidative Stress; Parathyroid Hormone; Phenols; Phosphorus; RAW 264.7 Cells; Risk Factors | 2016 |
Endogenous intact PTH is suppressed during Teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis.
Topics: Aged; Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Calcium; Female; Follow-Up Studies; Humans; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Teriparatide | 2008 |
Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients.
Topics: Adult; Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Calcitonin; Calcium; Calcium Carbonate; Drug Administration Schedule; Female; Femur Neck; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Renal Dialysis | 2008 |
Effects of ipriflavone on postmenopausal syndrome and osteoporosis.
Topics: Acid Phosphatase; Adult; Alanine Transaminase; Bone Density; Bone Remodeling; Calcium; Double-Blind Method; Female; Humans; Isoenzymes; Isoflavones; Menopause; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Phytoestrogens; Statistics, Nonparametric; Tartrate-Resistant Acid Phosphatase | 2010 |
Effects of bisphosphonate treatment on circulating osteogenic endothelial progenitor cells in postmenopausal women.
Topics: Biomarkers; Bone Density; Bone Density Conservation Agents; C-Reactive Protein; Calcium; Creatinine; Double-Blind Method; Down-Regulation; Endothelium; Enzyme-Linked Immunosorbent Assay; Etidronic Acid; Female; Flow Cytometry; Gene Expression Regulation; Humans; Interleukin-8; Middle Aged; Osteoblasts; Osteogenesis; Osteoporosis, Postmenopausal; Osteoprotegerin; Phosphorus; Placebos; RANK Ligand; Risedronic Acid; Stem Cells; Treatment Outcome; Vitamin D | 2013 |
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis.
Topics: Alkaline Phosphatase; Bone Density; Bone Resorption; Calcium; Diphosphonates; Drug Therapy, Combination; Female; Humans; Hydroxycholecalciferols; Infusions, Intravenous; Insulin-Like Growth Factor I; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Pamidronate; Parathyroid Hormone; Phosphorus; Prospective Studies; Sodium Fluoride; Time Factors; Treatment Outcome | 2003 |
Early response to alendronate after treatment with etidronate in postmenopausal women with osteoporosis.
Topics: Aged; Aged, 80 and over; Alendronate; Back Pain; Bone Density; Calcium; Collagen; Collagen Type I; Etidronic Acid; Female; Humans; Incidence; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Pain Measurement; Peptides; Phosphorus; Radiography; Spinal Fractures | 2003 |
Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
Topics: Aged; Calcium; Calcium Citrate; Calcium Phosphates; Citric Acid; Dietary Supplements; Drug Therapy, Combination; Female; Humans; Hydrogen-Ion Concentration; Middle Aged; Osteoporosis, Postmenopausal; Oxalates; Phosphorus; Postmenopause; Potassium Citrate; Risk Factors; Uric Acid; Urinary Calculi | 2004 |
Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis: a 3-year follow-up study.
Topics: Aged; Alendronate; Alkaline Phosphatase; Bone Density; Calcium; Female; Follow-Up Studies; Humans; Incidence; Japan; Lumbar Vertebrae; Osteoporosis, Postmenopausal; Phosphorus; Radiography; Spinal Fractures | 2004 |
Determinants of one-year response of lumbar bone mineral density to alendronate treatment in elderly Japanese women with osteoporosis.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Alendronate; Alkaline Phosphatase; Bone Density; Calcium; Collagen; Collagen Type I; Female; Humans; Incidence; Japan; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Peptides; Phosphorus; Spinal Fractures | 2004 |
Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate.
Topics: Accidental Falls; Aged; Aged, 80 and over; Alendronate; Alkaline Phosphatase; Back Pain; Bone Density; Bone Remodeling; Calcium; Chronic Disease; Exercise; Female; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Vibration | 2005 |
Cyclical alendronate treatment in postmenopausal women with osteoporosis.
Topics: Alendronate; Alkaline Phosphatase; Amino Acids; Bone Density; Bone Density Conservation Agents; Calcium; Drug Administration Schedule; Etidronic Acid; Female; Humans; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Phosphorus | 2005 |
Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Bone Density; Calcium; Collagen; Collagen Type I; Creatine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Kidney Function Tests; Middle Aged; Osteoporosis, Postmenopausal; Peptide Fragments; Peptides; Phosphorus; Procollagen; Raloxifene Hydrochloride; Teriparatide; Treatment Outcome; Uric Acid; Vomiting | 2005 |
Dietary phylloquinone depletion and repletion in postmenopausal women: effects on bone and mineral metabolism.
Topics: Aged; Aged, 80 and over; Biomarkers; Calcitriol; Calcium; Collagen Type I; Female; Humans; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Peptides; Phosphorus; Vitamin K 1; Vitamin K Deficiency; Vitamins | 2006 |
The effect of alendronate, risedronate, and raloxifene on renal functions, based on the Cockcroft and Gault method, in postmenopausal women.
Topics: Aged; Alendronate; Bone Density Conservation Agents; C-Reactive Protein; Calcium; Etidronic Acid; Female; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Raloxifene Hydrochloride; Risedronic Acid; Uric Acid | 2007 |
Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Topics: Amino Acids; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Calcium; Cytokines; Female; Humans; Interleukin-6; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Transforming Growth Factor beta1; Treatment Outcome; Tumor Necrosis Factor-alpha; Vitamin D | 2007 |
Prevention of bone loss after withdrawal of tamoxifen.
Topics: Absorptiometry, Photon; Administration, Oral; Alendronate; Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Calcium; Double-Blind Method; Drug Administration Schedule; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Serum Albumin; Substance Withdrawal Syndrome; Tamoxifen; Treatment Outcome | 2008 |
Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.
Topics: Absorptiometry, Photon; Administration, Oral; Aged; Body Height; Body Weight; Bone Density; Bone Development; Bone Resorption; Calcitriol; Cross-Sectional Studies; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Femur Neck; Humans; Lumbar Vertebrae; Medroxyprogesterone Acetate; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus | 1995 |
Determinants of endogenous fecal calcium in healthy women.
Topics: Absorption; Adult; Body Constitution; Body Weight; Calcium; Calcium, Dietary; Eating; Feces; Female; Humans; Isotope Labeling; Italy; Longitudinal Studies; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Phosphorus, Dietary; Prospective Studies; Regression Analysis | 1994 |
Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Biomarkers; Bone and Bones; Bone Density; Bone Development; Bone Resorption; Calcium; Female; Growth Hormone; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Recombinant Proteins; Vitamin D; White People | 1995 |
Vertebral and metacarpal morphometry as indicators of nutritional improvement.
Topics: Absorptiometry, Photon; Adult; Analysis of Variance; Bone Density; Dietary Carbohydrates; Dietary Fats; Female; Humans; Linear Models; Metacarpus; Middle Aged; Nutrition Disorders; Nutrition Surveys; Osteoporosis, Postmenopausal; Phosphorus; Postmenopause; Premenopause; Sensitivity and Specificity; Spain; Spine | 1997 |
A placebo-controlled, single-blind study to determine the appropriate alendronate dosage in postmenopausal Japanese patients with osteoporosis. The Alendronate Research Group.
Topics: Adult; Aged; Alendronate; Alkaline Phosphatase; Amino Acids; Bone Density; Bone Diseases, Metabolic; Calcium; Female; Humans; Japan; Kinetics; Lumbar Vertebrae; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Placebos | 1998 |
Early postmenopausal bone loss is prevented by estrogen and partially by 1alpha-OH-vitamin D3: therapeutic effects of estrogen and/or 1alpha-OH-vitamin D3.
Topics: Adult; Alkaline Phosphatase; Bone Density; Calcium; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Femur Neck; Humans; Hydroxycholecalciferols; Hydroxyproline; Lumbar Vertebrae; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus | 1999 |
Calcitriol and alendronate combination treatment in menopausal women with low bone mass.
Topics: Aged; Alendronate; Calcitriol; Calcium; Calcium Channel Agonists; Calcium, Dietary; Drug Therapy, Combination; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus | 1999 |
Effect of exercise training and detraining on bone mineral density in postmenopausal women with osteoporosis.
Topics: Aged; Alkaline Phosphatase; Bone Density; Calcium; Exercise; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus | 2001 |
Comparison of different treatment modalities for postmenopausal patients with osteopenia: hormone replacement therapy, calcitonin and clodronate.
Topics: Adult; Alkaline Phosphatase; Bone Density; Calcitonin; Calcium; Clodronic Acid; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Femur; Humans; Lumbar Vertebrae; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Phosphorus; Treatment Outcome | 2000 |
Menopausal bone loss is partially regulated by dietary intake of vitamin D.
Topics: 25-Hydroxyvitamin D 2; Absorptiometry, Photon; Administration, Oral; Adult; Ascorbic Acid; Bone Density; Calcifediol; Calcium; Cross-Sectional Studies; Estrogens; Female; Follicle Stimulating Hormone; Food, Fortified; Humans; Middle Aged; Minerals; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Radius; Time Factors; Vitamin D | 1992 |
Effect of calcium pidolate on biochemical and hormonal parameters in involutional osteoporosis.
Topics: Aged; Alkaline Phosphatase; Calcium; Creatinine; Female; Growth Hormone; Hormones; Humans; Hydroxyproline; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Pyrrolidonecarboxylic Acid | 1990 |
A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement.
Topics: Adult; Biopsy; Bone Density; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometrium; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Phosphorus | 1990 |
Estimated long-term effect of calcitonin treatment in acute osteoporotic spine fractures.
Topics: Aged; Bone and Bones; Calcitonin; Calcium; Estradiol; Female; Fractures, Spontaneous; Humans; Middle Aged; Minerals; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Phosphorus; Prospective Studies; Random Allocation; Spinal Injuries; Time Factors | 1989 |
66 other study(ies) available for phosphorus and Bone Loss, Perimenopausal
Article | Year |
---|---|
Effect of continuous long-term treatment for 10 years with bisphosphonate on Japanese osteoporosis patients.
Topics: Aged; Aged, 80 and over; Alendronate; Alkaline Phosphatase; Asian People; Bone Density; Calcium; Collagen Type I; Diphosphonates; Female; Humans; Japan; Osteoporosis; Osteoporosis, Postmenopausal; Peptides; Phosphorus; Retrospective Studies; Risedronic Acid; Tartrate-Resistant Acid Phosphatase; Time Factors; Treatment Outcome | 2020 |
Effects of alendronate and calcifediol compared to alendronate and cholecalciferol in osteoporotic patients.
Topics: Aged; Alendronate; Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Calcifediol; Calcium; Cholecalciferol; Drug Therapy, Combination; Exercise; Female; Femur; Humans; Lumbar Vertebrae; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Retrospective Studies; Vitamin D | 2019 |
Inverse association between bone mineral density and fibrinogen in menopausal women.
Topics: Alkaline Phosphatase; Body Mass Index; Bone Density; Bone Diseases, Metabolic; Calcium; Cross-Sectional Studies; Estradiol; Female; Fibrinogen; Humans; Linear Models; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Regression Analysis | 2021 |
Evaluation of ostarine as a selective androgen receptor modulator in a rat model of postmenopausal osteoporosis.
Topics: Alkaline Phosphatase; Anilides; Animals; Biomechanical Phenomena; Body Weight; Bone Density; Dose-Response Relationship, Drug; Female; Femur; Humans; Minerals; Muscles; Organ Size; Osteoporosis, Postmenopausal; Ovariectomy; Phosphorus; RANK Ligand; Rats, Sprague-Dawley; Receptors, Androgen; RNA, Messenger; Spine; X-Ray Microtomography | 2019 |
Assessing periapical dental radiographs as a screening parameter for early indications of osteoporosis in postmenopausal periodontal patients and root surface evaluation using spectrochemical analysis.
Topics: Aged; Bone Density; Calcium; Chronic Periodontitis; Comorbidity; Dental Plaque Index; Female; Fluorides; Gingival Pocket; Humans; Magnesium; Mass Screening; Middle Aged; Osteoporosis, Postmenopausal; Periodontal Index; Phosphorus; Postmenopause; Potassium; Radiography, Dental; Saudi Arabia; Spectrum Analysis; Tooth Root | 2018 |
Efficacy and safety of recombinant human parathyroid hormone (1-34) are similar to those of alendronate in the treatment of postmenopausal osteoporosis.
Topics: Aged; Alendronate; Alkaline Phosphatase; Becaplermin; Bone Density; Bone Density Conservation Agents; Calcium; Collagen Type I; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Peptide Fragments; Peptides; Phosphorus; Procollagen; Teriparatide; Treatment Outcome; Triglycerides; Vascular Endothelial Growth Factor A | 2018 |
LncRNAp21 promotes osteogenic differentiation of mesenchymal stem cells in the rat model of osteoporosis by the Wnt/β-catenin signaling pathway.
Topics: Animals; beta Catenin; Bone Density; Bone Resorption; Calcium; Cell Differentiation; Estradiol; Female; Humans; Mesenchymal Stem Cells; Osteogenesis; Osteoporosis, Postmenopausal; Ovariectomy; Phosphorus; Rats; RNA, Long Noncoding; Wnt Signaling Pathway | 2019 |
Combination treatment with Fructus Ligustri Lucidi and Puerariae radix offsets their independent actions on bone and mineral metabolism in ovariectomized rats.
Topics: Animals; Biomarkers; Body Weight; Bone and Bones; Bone Density; Calcium; Disease Models, Animal; Drug Interactions; Drugs, Chinese Herbal; Female; Fruit; Humans; Hyperparathyroidism; Intestinal Absorption; Ligustrum; Minerals; Organ Size; Osteoporosis, Postmenopausal; Ovariectomy; Phosphorus; Phytotherapy; Plant Preparations; Postmenopause; Pueraria; Rats; Rats, Sprague-Dawley; Tomography, X-Ray Computed; Uterus | 2014 |
Applicability of ToF-SIMS for monitoring compositional changes in bone in a long-term animal model.
Topics: Animals; Bone Density; Calcium; Collagen; Disease Models, Animal; Female; Humans; Lumbar Vertebrae; Osteoporosis, Postmenopausal; Ovariectomy; Phosphorus; Rats; Spectrometry, Mass, Secondary Ion; Time Factors | 2013 |
Influence of estrogen therapy on calcium, phosphorus, and other regulatory hormones in postmenopausal women: the MESA study.
Topics: 24,25-Dihydroxyvitamin D 3; 25-Hydroxyvitamin D 2; Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Bone Density; Calcifediol; Calcium; Cohort Studies; Cross-Sectional Studies; Ergocalciferols; Estrogen Replacement Therapy; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Radiography; Vitamin D | 2013 |
The relationship between fibroblast growth factor 23 and osteoporosis in postmenopausal women.
Topics: Alkaline Phosphatase; Biomarkers; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Calcium; Case-Control Studies; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hydroxyproline; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Vitamin D | 2013 |
[Association between bone turnover markers, bone mineral density and vitamin D in Moroccan postmenopausal women].
Topics: Aged; Alkaline Phosphatase; Asymptomatic Diseases; Biomarkers; Body Mass Index; Bone Density; Bone Remodeling; Calcium; Cross-Sectional Studies; Female; Femur Neck; Humans; Lumbar Vertebrae; Middle Aged; Morocco; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Postmenopause; Radiography; Vitamin D | 2014 |
Changes of serum cytokines-related Th1/Th2/Th17 concentration in patients with postmenopausal osteoporosis.
Topics: Alkaline Phosphatase; Calcium; Cytokines; Female; Humans; Magnesium; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus | 2015 |
Olive oil in the prevention and treatment of osteoporosis after artificial menopause.
Topics: Absorptiometry, Photon; alpha-Fetoproteins; Animals; Anti-Inflammatory Agents; Antigens, Tumor-Associated, Carbohydrate; Antioxidants; Bone Density; Calcium; Carcinoembryonic Antigen; Estrogens; Female; Humans; Interleukin-6; Malondialdehyde; Nitrates; Olive Oil; Osteoporosis, Postmenopausal; Phosphorus; Plant Oils; Rats; Rats, Sprague-Dawley | 2014 |
[Clinical efficacy instant goat milk in the complex therapy and prevention of osteoporosis in patients with rheumatoid arthritis].
Topics: Animals; Arthritis, Rheumatoid; Calcifediol; Calcitriol; Calcium; Female; Goats; Humans; Male; Middle Aged; Milk; Osteoporosis, Postmenopausal; Phosphorus | 2014 |
Anti-osteoporotic activity of puerarin 6"-O-xyloside on ovariectomized mice and its potential mechanism.
Topics: Alkaline Phosphatase; Animals; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Bone Remodeling; Calcium; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glycosides; Humans; Isoflavones; Mice, Inbred ICR; Osteoblasts; Osteoporosis, Postmenopausal; Osteoprotegerin; Ovariectomy; Phosphorus; RANK Ligand; Time Factors | 2016 |
Influence of single nucleotide polymorphisms of vitamin D receptor-gene on the level of osteoassociated hormones linkage with postmenopausal osteoporosis.
Topics: Alkaline Phosphatase; Alleles; Bone Density; Calcium; Case-Control Studies; Deoxyribonucleases, Type II Site-Specific; Female; Gene Expression; Genotype; Heterozygote; Homozygote; Humans; Interleukin-1beta; Magnesium; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Postmenopause; Progesterone; Receptors, Calcitriol; Testosterone | 2015 |
Bisphosphonates--what the dentist needs to know: practical considerations.
Topics: Aged; Arthritis, Juvenile; Biomarkers; Bone Density Conservation Agents; Bone Neoplasms; Bone Remodeling; Collagen Type I; Contraindications; Dental Care for Chronically Ill; Dental Implantation, Endosseous; Diphosphonates; Female; Glucocorticoids; Humans; Jaw Diseases; Kidney Neoplasms; Male; Middle Aged; Nitrogen; Osteonecrosis; Osteoporosis, Postmenopausal; Peptides; Phosphorus; Tooth Extraction | 2009 |
The relationship between back pain and future vertebral fracture in postmenopausal women.
Topics: Aged; Alkaline Phosphatase; Back Pain; Blood Proteins; Bone Density; Calcium; Comorbidity; Female; Humans; Japan; Middle Aged; Multivariate Analysis; Odds Ratio; Osteoporosis, Postmenopausal; Phosphorus; Postmenopause; Prevalence; Regression Analysis; Risk Factors; Spinal Fractures | 2009 |
Effect of tetracalcium dimagnesium phytate on bone characteristics in ovariectomized rats.
Topics: Amino Acids; Animals; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Calcium; Calcium, Dietary; Diet; Disease Models, Animal; Female; Femur; Humans; Lumbar Vertebrae; Magnesium; Osteocalcin; Osteogenesis; Osteoporosis, Postmenopausal; Phosphorus; Phytic Acid; Random Allocation; Rats; Rats, Wistar | 2010 |
Effects of raloxifene on bone mineral metabolism in postmenopausal Japanese women on hemodialysis.
Topics: Absorptiometry, Photon; Aged; Asian People; Bone Density; Bone Density Conservation Agents; Calcium; Case-Control Studies; Collagen Type I; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Peptides; Phosphorus; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Renal Dialysis; Severity of Illness Index; Time Factors | 2011 |
PTH level but not 25 (OH) vitamin D level predicts bone loss rates in the elderly.
Topics: Aged; Aged, 80 and over; Biomarkers; Body Composition; Body Mass Index; Bone Density; Calcium; Calcium, Dietary; Creatinine; Female; Follow-Up Studies; Humans; Lebanon; Male; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Predictive Value of Tests; Vitamin D | 2012 |
[Comparative study of the urinary excretion of boron, calcium, magnesium and phosphorus in postmenopausal women with and without osteoporosis].
Topics: Aged; Boron; Calcium; Creatinine; Female; Homeostasis; Humans; Linear Models; Magnesium; Middle Aged; Models, Biological; Osteoporosis, Postmenopausal; Phosphorus; Postmenopause; Spectrophotometry, Atomic | 2012 |
Kidney function and age related mineral imbalance in postmenopausal women with osteopenia/osteoporosis.
Topics: Aged; Aging; Bone Density; Bone Diseases, Metabolic; Calcium; Cholecalciferol; Creatinine; Female; Humans; Kidney; Magnesium; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus | 2003 |
Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis.
Topics: Aged; Alendronate; Alkaline Phosphatase; Biomarkers; Bone Density; Calcium; Collagen; Collagen Type I; Female; Humans; Japan; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Peptides; Phosphorus; Time Factors | 2005 |
[Effectiveness of intranasal salmon calcitonin treatment in postmenopausal osteoporosis].
Topics: Administration, Intranasal; Adult; Aged; Analgesics; Bone Density; Calcitonin; Calcium; Densitometry; Female; Follow-Up Studies; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Treatment Outcome | 2005 |
The relationship of vitamin D status to bone mineral density in an Italian population of postmenopausal women.
Topics: Absorptiometry, Photon; Aged; Biomarkers; Bone Density; Bone Density Conservation Agents; Calcifediol; Calcitriol; Calcium; Creatinine; Female; Femur Neck; Humans; Italy; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Postmenopause; Predictive Value of Tests; Retrospective Studies; Spine; Vitamin D | 2005 |
[Assessment of cortical bone mineral density and biochemical markers of bone metabolism in postmenopausal osteoporosis].
Topics: Adult; Age Factors; Aged; Biomarkers; Bone and Bones; Bone Density; Calcium; Female; Humans; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Phosphorus; Ultrasonography | 2005 |
Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
Topics: Alkaline Phosphatase; Amino Acids; Bilirubin; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Calcium; Chronic Disease; Cross-Sectional Studies; Female; Femur; Humans; Liver Diseases; Lumbar Vertebrae; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Postmenopause | 2005 |
Effects of soy isoflavone and/or estrogen treatments on bone metabolism in ovariectomized rats.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Biomechanical Phenomena; Body Weight; Bone and Bones; Calcium; Calcium, Dietary; Creatinine; Eating; Estrogens; Female; Femur; Glycine max; Humans; Hydroxyproline; Isoflavones; Osteoporosis, Postmenopausal; Ovariectomy; Phosphates; Phosphorus; Rats; Rats, Sprague-Dawley | 2005 |
Acute changes in serum osteoprotegerin and receptor activator for nuclear factor-kappaB ligand levels in women with established osteoporosis treated with teriparatide.
Topics: Aged; Alkaline Phosphatase; Bone and Bones; Bone Density Conservation Agents; Calcium; Female; Humans; Osteoporosis, Postmenopausal; Osteoprotegerin; Phosphorus; Prospective Studies; RANK Ligand; Teriparatide | 2008 |
Serum prolidase activity in postmenopausal osteoporosis.
Topics: Adult; Aged; Alkaline Phosphatase; Biomarkers; Bone Density; Bone Remodeling; Calcium; Case-Control Studies; Creatinine; Dipeptidases; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus | 2007 |
Circulating profiles of osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand in post-menopausal women.
Topics: Alkaline Phosphatase; Bone Density; Calcium; Collagen Type I; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Osteoprotegerin; Parathyroid Hormone; Peptides; Phosphorus; Postmenopause; RANK Ligand; Solubility | 2008 |
Curculigo orchioides, a traditional Chinese medicinal plant, prevents bone loss in ovariectomized rats.
Topics: Animals; Bone Density; Bone Resorption; Calcium; Curculigo; Disease Models, Animal; Drugs, Chinese Herbal; Female; Humans; Osteoporosis, Postmenopausal; Phosphorus; Phytotherapy; Rats; Rats, Sprague-Dawley; Rhizome | 2008 |
The effects of menopause and age on calcitropic hormones: a cross-sectional study of 655 healthy women aged 35 to 90.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alkaline Phosphatase; Bone Development; Bone Resorption; Calcitriol; Calcium; Cohort Studies; Creatinine; Cross-Sectional Studies; Female; Humans; Hydroxyproline; Longitudinal Studies; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Postmenopause; Serum Albumin; Vitamin D-Binding Protein | 1995 |
The relationship of nutritional copper to the development of postmenopausal osteoporosis in rats.
Topics: Animals; Bone Density; Bone Diseases, Metabolic; Calcium; Copper; Diet; Disease Models, Animal; Estradiol; Female; Femur; Humans; Osteoporosis, Postmenopausal; Ovariectomy; Phosphorus; Random Allocation; Rats; Rats, Sprague-Dawley | 1995 |
[Effect of natural calcium against osteopenia in ovariectomized rats].
Topics: Alkaline Phosphatase; Animals; Bone and Bones; Calcium; Female; Humans; Osteoporosis, Postmenopausal; Ovariectomy; Phosphorus; Rats; Rats, Wistar | 1995 |
[Cortisone, phosphorus-calcium metabolism and osteoporosis].
Topics: Adrenal Cortex Hormones; Adult; Calcium; Female; Humans; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Phosphorus; Risk Factors; Sex Factors | 1995 |
[Influence of refined amorphophallus konjac on osteoporosis in the aged female rats: a preliminary bone histomorphometric analysis].
Topics: Animals; Bone Density; Calcium; Dietary Fiber; Female; Humans; Mannans; Osteoporosis, Postmenopausal; Phosphorus; Rats; Rats, Sprague-Dawley | 1994 |
The influence of dichloromethylene bisphosphonate on the healing of a long bone fracture, composition of bone mineral and histology of bone in the rat.
Topics: Animals; Body Weight; Bone Density; Calcium; Clodronic Acid; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking; Female; Femoral Fractures; Femur; Fluorides; Fracture Healing; Humans; Injections, Subcutaneous; Magnesium; Osteocalcin; Osteoporosis, Postmenopausal; Phosphorus; Rats; Rats, Sprague-Dawley | 1994 |
The effect of tochu bark on bone metabolism in the rat model with ovariectomized osteoporosis.
Topics: Animals; Bone and Bones; Bone Density; Calcium; Diet; Disease Models, Animal; Female; Humans; Intestinal Absorption; Osteoporosis, Postmenopausal; Ovariectomy; Phosphorus; Plant Extracts; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Tensile Strength | 1994 |
Calcium, phosphorus and magnesium intakes correlate with bone mineral content in postmenopausal women.
Topics: Aged; Bone Density; Calcium, Dietary; Diet; Female; Humans; Magnesium; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Postmenopause | 1994 |
Osteoporosis by ovariectomy: calcitonin effect in an experimental model on the rat.
Topics: Alkaline Phosphatase; Animals; Bone Density; Calcitonin; Calcium; Disease Models, Animal; Female; Humans; Lumbar Vertebrae; Minerals; Osteocalcin; Osteoporosis, Postmenopausal; Ovariectomy; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley | 1993 |
[Prevention of post-ovariectomy osteoporosis in the rat. Comparative study of synthetic salmon calcitonin and eel calcitonin aminosuberic analogue].
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Animals; Biomarkers; Bone Resorption; Calcitonin; Calcium; Female; Humans; Osteocalcin; Osteoporosis, Postmenopausal; Ovariectomy; Phosphorus; Rats; Rats, Sprague-Dawley | 1993 |
Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate.
Topics: Aged; Bicarbonates; Bone and Bones; Bone Density; Bone Resorption; Calcium; Female; Humans; Middle Aged; Minerals; Osteoporosis, Postmenopausal; Phosphorus; Postmenopause; Potassium; Potassium Compounds; Sodium | 1994 |
Bone loss in young women with primary hypogonadism and its prevention with calcitonin.
Topics: Absorptiometry, Photon; Administration, Intranasal; Adult; Alkaline Phosphatase; Analysis of Variance; Bone Density; Calcitonin; Calcium; Chi-Square Distribution; Cholesterol; Creatinine; Female; Humans; Hypogonadism; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Phosphorus; Postmenopause; Prospective Studies | 1993 |
[Observations on bone mineral metabolism in natural and surgical menopause. Role of synthetic salmon calcitonin and calcium on bone turnover].
Topics: Adult; Bone and Bones; Bone Density; Calcification, Physiologic; Calcitonin; Calcium; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Ovariectomy; Phosphorus | 1993 |
The effect of ovariectomy on periosteal bone formation and bone resorption in adult rats.
Topics: Animals; Bone and Bones; Bone Resorption; Calcium; Disease Models, Animal; Female; Humans; Osteoblasts; Osteogenesis; Osteoporosis, Postmenopausal; Ovariectomy; Ovary; Phosphorus; Rats; Rats, Wistar | 1993 |
Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis.
Topics: Acid Phosphatase; Alkaline Phosphatase; Analysis of Variance; Animals; Body Weight; Bone and Bones; Bone Resorption; Calcitriol; Calcium; Diet; Eating; Estradiol; Female; Humans; Isoenzymes; Osteoporosis, Postmenopausal; Ovariectomy; Phosphorus; Plant Proteins, Dietary; Random Allocation; Rats; Rats, Sprague-Dawley; Soybean Proteins; Tartrate-Resistant Acid Phosphatase; Vitamin D | 1996 |
Dietary casein phosphopeptides prevent bone loss in aged ovariectomized rats.
Topics: Aging; Alkaline Phosphatase; Animals; Body Weight; Bone Density; Bone Resorption; Calcitriol; Calcium; Caseins; Dietary Proteins; Disease Models, Animal; Female; Humans; Osteocalcin; Osteoporosis, Postmenopausal; Ovariectomy; Phosphopeptides; Phosphorus; Rats; Rats, Wistar | 1996 |
Short- and long-term effects of calcitonin and calcium administration on blood calcium, magnesium and inorganic phosphorus in post menopausal osteoporosis.
Topics: Aged; Analysis of Variance; Calcitonin; Calcium; Female; Humans; Injections, Intramuscular; Magnesium; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus | 1995 |
The effect of estrogen replacement therapy on zinc in serum and urine.
Topics: Bone Density; Creatinine; Estrogen Replacement Therapy; Female; Humans; Hydroxyproline; Magnesium; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Zinc | 1996 |
The effect of estrogen deficiency on bone mineral density, renal calcium and phosphorus handling and calcitropic hormones in the rat.
Topics: Absorptiometry, Photon; Analysis of Variance; Animals; Biomarkers; Bone Density; Calcitriol; Calcium; Calcium, Dietary; Disease Models, Animal; Estrogens; Female; Glomerular Filtration Rate; Humans; Kidney; Menopause; Osteoporosis, Postmenopausal; Ovariectomy; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary; Rats; Rats, Sprague-Dawley | 1996 |
Decreased bone mineral density associated with early menopause progresses for at least ten years: cross-sectional comparisons between early and normal menopausal women.
Topics: Adult; Aging; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Calcitonin; Calcium; Cohort Studies; Creatinine; Cross-Sectional Studies; Estradiol; Female; Follicle Stimulating Hormone; Humans; Japan; Lumbar Vertebrae; Luteinizing Hormone; Menopause, Premature; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Risk Factors | 1996 |
Effect of ovariectomy on bone histology and plasma parameters of bone metabolism in nulliparous and multiparous sows.
Topics: Aging; Alkaline Phosphatase; Animals; Biomarkers; Bone and Bones; Bone Density; Calcifediol; Calcitriol; Calcium; Disease Models, Animal; Female; Humans; Organ Size; Osteoporosis, Postmenopausal; Ovariectomy; Parathyroid Hormone; Parity; Phosphorus; Swine; Uterus | 1996 |
Diminished effect of etidronate in vitamin D deficient osteopenic postmenopausal women.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Density; Calcium; Creatinine; Drug Administration Schedule; Etidronic Acid; Female; Humans; Magnesium; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Vitamin D Deficiency | 1996 |
Calcium bioavailability of a total bone extract (TBE) and its effects on bone metabolism in rats.
Topics: Animals; Biological Availability; Biomarkers; Bone Density; Calcium; Calcium Carbonate; Citric Acid; Female; Femur; Humans; Intestinal Absorption; Lactic Acid; Magnesium; Male; Osteoporosis, Postmenopausal; Ovariectomy; Phosphorus; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Tissue Extracts | 1998 |
Serum levels of cross-linked N-telopeptides and aminoterminal propeptides of type I collagen indicate low bone mineral density in elderly women.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Aging; Biomarkers; Bone Density; Calcium; Collagen; Collagen Type I; Enzyme-Linked Immunosorbent Assay; Estrogen Replacement Therapy; Female; Femur Neck; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Peptide Fragments; Peptides; Phosphorus; Procollagen | 1998 |
Comparative study of a biochemical index for the estimation of bone demineralization and dual photon absorptiometry.
Topics: Absorptiometry, Photon; Adult; Alkaline Phosphatase; Bone Demineralization, Pathologic; Bone Density; Calcium; Estradiol; Female; Humans; Isoenzymes; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Progesterone; Reference Values | 1995 |
Acute effects of ovariectomy on wound healing of alveolar bone after maxillary molar extraction in aged rats.
Topics: Acute Disease; Aging; Animals; Bone Regeneration; Calcium; Estrogens; Female; Humans; Maxilla; Microscopy, Electron, Scanning; Molar; Osteoporosis, Postmenopausal; Ovariectomy; Phosphorus; Rats; Rats, Wistar; Tooth Extraction; Tooth Socket; Wound Healing | 2001 |
[New calcium-containing product for complex treatment of osteoporosis].
Topics: Age Factors; Aged; Aged, 80 and over; Bone Density; Calcium; Calcium, Dietary; Female; Humans; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Phosphorus | 2001 |
[Calcium-phosphorus metabolism and bone metabolism in postmenopausal patients with the thyroid gland pathology].
Topics: Alkaline Phosphatase; Bone and Bones; Calcitonin; Calcium; Female; Goiter, Endemic; Humans; Hydroxyproline; Hypothyroidism; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Thyroid Hormones | 2002 |
Effect of cyclical therapy with phosphorus and etidronate on axial bone mineral density in postmenopausal osteoporotic women.
Topics: Aged; Bone Density; Drug Administration Schedule; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Prospective Studies; Sodium Fluoride | 1991 |
[Clinical study of concerning factors of decreased bone mineral content in hemodialysis patients].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alkaline Phosphatase; Aluminum; Aluminum Hydroxide; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Renal Dialysis; Sex Factors | 1991 |
Role of calcitriol in prevention of osteoporosis: Part I.
Topics: Animals; Bone Density; Calcitriol; Calcium; Creatinine; Dogs; Female; Humans; Hydroxycholecalciferols; Osteoporosis, Postmenopausal; Phosphorus | 1990 |
[Effect of estrogen replacement therapy on the serum osteocalcin level in the postmenopausal and castrated women].
Topics: Adult; Alkaline Phosphatase; Calcium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Menopause; Middle Aged; Osteocalcin; Osteoporosis; Osteoporosis, Postmenopausal; Ovariectomy; Phosphorus | 1989 |